Farbod Shahabinezhad
Overview
Explore the profile of Farbod Shahabinezhad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
36
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dehghani Z, Ranjbar S, Shahabinezhad F, Sabouri P, Mohammadi Bardbori A
Toxicol Res (Camb)
. 2024 Sep;
13(5):tfae151.
PMID: 39323479
Introduction: The number of new diagnosed cancer cases and cancer deaths are increasing worldwide. Perfluorinated compounds (PFCs) are synthetic chemicals, which are possible inducers of cancer in human and laboratory...
2.
Moradi A, Shahabinezhad F, Dehshahri A
Iran J Basic Med Sci
. 2023 Jul;
26(8):934-940.
PMID: 37427327
Objectives: Huntington's disease (HD) is identified as a progressive genetic disorder caused by a mutation in the Huntington gene. Although the pathogenesis of this disease has not been fully understood,...
3.
Shafiekhani M, Shahabinezhad F, Tavakoli Z, Tarakmeh T, Haem E, Sari N, et al.
Front Pharmacol
. 2023 Mar;
14:1051350.
PMID: 36909168
Transplanted organ survival after solid organ transplantation highly correlates with the adherence levels of the patients to their immunosuppressive drugs. On the other hand, one of the main goals of...
4.
Azadi S, Shahabinezhad F, Shafiekhani M
Iran J Med Sci
. 2022 Nov;
47(6):577-587.
PMID: 36380982
Background: Transplanted patients receiving immunosuppressive agents are at a higher risk of Coronavirus-disease-2019 (COVID-19), and their polypharmacy state makes the choice of treatment challenging. This study aimed to assess the...
5.
Shafiekhani M, Shahabinezhad F, Niknam T, Tara S, Haem E, Mardani P, et al.
Virol J
. 2021 Nov;
18(1):228.
PMID: 34809657
Background: The management of COVID-19 in organ transplant recipients is among the most imperative, yet less discussed, issues based on their immunocompromised status along with their vast post-transplant medication regimens....
6.
Mosaddeghi P, Eslami M, Farahmandnejad M, Akhavein M, Ranjbarfarrokhi R, Khorraminejad-Shirazi M, et al.
Sci Rep
. 2021 Jun;
11(1):12481.
PMID: 34103638
No abstract available.
7.
Mosaddeghi P, Eslami M, Farahmandnejad M, Akhavein M, Ranjbarfarrokhi R, Khorraminejad-Shirazi M, et al.
Sci Rep
. 2021 Jan;
11(1):336.
PMID: 33431946
Aging is correlated with several complex diseases, including type 2 diabetes, neurodegeneration diseases, and cancer. Identifying the nature of this correlation and treatment of age-related diseases has been a major...
8.
Mosaddeghi P, Shahabinezhad F, Dorvash M, Goodarzi M, Negahdaripour M
Hum Vaccin Immunother
. 2020 Nov;
17(6):1650-1661.
PMID: 33185497
No proven remedy is identified for COVID-19 yet. SARS-CoV-2, the viral agent, is recognized by some endosomal and cytosolic receptors following cell entry, entailing innate and adaptive immunity stimulation, notably...